The Ig superfamily protein PTGFRN coordinates survival signaling in glioblastoma multiforme.

作者: Brittany Aguila , Adina Brett Morris , Raffaella Spina , Eli Bar , Julie Schraner

DOI: 10.1016/J.CANLET.2019.07.018

关键词:

摘要: Glioblastoma multiforme (GBM) is the most malignant primary brain tumor with a median survival of approximately 14 months. Despite aggressive treatment surgical resection, chemotherapy and radiation therapy, only 3-5% GBM patients survive more than 3 years. Contributing to this poor therapeutic response, it believed that contains both intrinsic acquired mechanisms resistance, including resistance therapy. In order define novel mediators we conducted functional knockdown screen, identified immunoglobulin superfamily protein, PTGFRN. GBM, PTGFRN found be overexpressed correlate survival. Reducing expression radiosensitizes cells potently decreases rate cell proliferation growth. Further, inhibition results in significant reduction PI3K p110β phosphorylated AKT, due instability p110β. Additionally, nuclear leading decreased DNA damage sensing repair. Therefore overexpression glioblastoma promotes AKT-driven signaling growth, as well increased repair signaling. These findings suggest potential hub for aggressiveness GBM.

参考文章(57)
Arnab Chakravarti, Gary G Zhai, Min Zhang, Rajeev Malhotra, Douglas E Latham, Meaghan A Delaney, Pierre Robe, Ulf Nestler, Qinhui Song, Jay Loeffler, Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms Oncogene. ,vol. 23, pp. 7494- 7506 ,(2004) , 10.1038/SJ.ONC.1208049
Tatyana N. Ignatova, Valery G. Kukekov, Eric D. Laywell, Oleg N. Suslov, Frank D. Vrionis, Dennis A. Steindler, Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia. ,vol. 39, pp. 193- 206 ,(2002) , 10.1002/GLIA.10094
Paul Foster, Kyoko Yamaguchi, Pin P Hsu, Fawn Qian, Xiangnan Du, Jianming Wu, Kwang-Ai Won, Peiwen Yu, Christopher T Jaeger, Wentao Zhang, Charles K Marlowe, Paul Keast, Wendy Abulafia, Jason Chen, Jenny Young, Artur Plonowski, F Michael Yakes, Felix Chu, Kelly Engell, Frauke Bentzien, Sanh T Lam, Stephanie Dale, Olivia Yturralde, David J Matthews, Peter Lamb, A Douglas Laird, None, The Selective PI3K Inhibitor XL147 (SAR245408) Inhibits Tumor Growth and Survival and Potentiates the Activity of Chemotherapeutic Agents in Preclinical Tumor Models Molecular Cancer Therapeutics. ,vol. 14, pp. 931- 940 ,(2015) , 10.1158/1535-7163.MCT-14-0833
S Colin, W Guilmain, E Creoff, C Schneider, C Steverlynck, M Bongaerts, E Legrand, J P Vannier, M Muraine, M Vasse, S Al-Mahmood, A truncated form of CD9-partner 1 (CD9P-1), GS-168AT2, potently inhibits in vivo tumour-induced angiogenesis and tumour growth British Journal of Cancer. ,vol. 105, pp. 1002- 1011 ,(2011) , 10.1038/BJC.2011.303
Erika Pastrana, Violeta Silva-Vargas, Fiona Doetsch, Eyes wide open: a critical review of sphere-formation as an assay for stem cells. Cell Stem Cell. ,vol. 8, pp. 486- 498 ,(2011) , 10.1016/J.STEM.2011.04.007
Sheila K. Singh, Cynthia Hawkins, Ian D. Clarke, Jeremy A. Squire, Jane Bayani, Takuichiro Hide, R. Mark Henkelman, Michael D. Cusimano, Peter B. Dirks, Identification of human brain tumour initiating cells Nature. ,vol. 432, pp. 396- 401 ,(2004) , 10.1038/NATURE03128
W Guilmain, S Colin, E Legrand, J P Vannier, C Steverlynck, M Bongaerts, M Vasse, S Al-Mahmood, CD9P-1 expression correlates with the metastatic status of lung cancer, and a truncated form of CD9P-1, GS-168AT2, inhibits in vivo tumour growth British Journal of Cancer. ,vol. 104, pp. 496- 504 ,(2011) , 10.1038/SJ.BJC.6606033
Magali André, Célia Chambrion, Stéphanie Charrin, Sabrina Soave, Joëlle Chaker, Claude Boucheix, Eric Rubinstein, François Le Naour, In situ chemical cross-linking on living cells reveals CD9P-1 cis-oligomer at cell surface Journal of Proteomics. ,vol. 73, pp. 93- 102 ,(2009) , 10.1016/J.JPROT.2009.08.005
E. M. Kass, H. R. Helgadottir, C.-C. Chen, M. Barbera, R. Wang, U. K. Westermark, T. Ludwig, M. E. Moynahan, M. Jasin, Double-strand break repair by homologous recombination in primary mouse somatic cells requires BRCA1 but not the ATM kinase Proceedings of the National Academy of Sciences of the United States of America. ,vol. 110, pp. 5564- 5569 ,(2013) , 10.1073/PNAS.1216824110